Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
2/07/2012
Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss
Children’s Memorial Hermann Hospital and Cord Blood Registry® (CBR) are launching the first FDA-approved, Phase I safety study on the use of cord blood stem cells to treat children with sensorineural hearing loss.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment